Insider Transactions in Q1 2024 at Oramed Pharmaceuticals Inc. (ORMP)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 30
2024
|
Daniel Aghion Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,750
+8.81%
|
-
|
|
Jan 04
2024
|
Joshua Hexter COO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
180,500
+27.25%
|
-
|
|
Jan 04
2024
|
Nadav Kidron President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
329,000
+15.59%
|
-
|
|
Jan 04
2024
|
Miriam Kidron Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
295,500
+27.9%
|
-
|
|
Jan 04
2024
|
Arie Mayer Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,325
+17.26%
|
-
|
|
Jan 04
2024
|
Yadin Rozov Director |
BUY
Grant, award, or other acquisition
|
Direct |
38,820
+11.19%
|
-
|
|
Jan 04
2024
|
Leonard Sank Director |
BUY
Grant, award, or other acquisition
|
Direct |
39,325
+16.98%
|
-
|
|
Jan 04
2024
|
David Silberman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
136,500
+27.14%
|
-
|
|
Jan 04
2024
|
Benjamin Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,070
+22.97%
|
-
|
|
Jan 04
2024
|
Daniel Aghion Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,070
+31.32%
|
-
|